Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
Raúl J. Andrade(Hospital Clínico Universitario Virgen de la Victoria), José Antonio Durán(Hospital Universitario Virgen Macarena), M. Carmen Fernández‐Santaella(Complejo Hospitalario Torrecárdenas), Rocío González‐Grande(Hospital Clínico Universitario Virgen de la Victoria), B. García‐Muñoz(Hospital Clínico Universitario Virgen de la Victoria), M. Isabel Lucena(Hospital Clínico Universitario Virgen de la Victoria), Gloria Isabel Carvajal Peláez(Universidad de Medellín), E. Garcia-Ruiz(Hospital Clínico Universitario Virgen de la Victoria), Ángeles Pizarro(Vall d'Hebron Hospital Universitari), Ketevan Pachkoria(Hospital Clínico Universitario Virgen de la Victoria)
Cited by 1,009
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Inflammatory Molecules in the Tears of Patients with Keratoconus
|Ophthalmology|2005|384
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry
|Hepatology|2006|306
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
|Journal of Hepatology|2022|172